<DOC>
	<DOCNO>NCT02200029</DOCNO>
	<brief_summary>A research study approve drug call Heptral® , ademetionine , treat adult intrahepatic cholestasis ( condition bile flow liver duodenum ) pre-cirrhotic cirrhotic state . Experience clinical study subject liver disease show ademetionine effective .</brief_summary>
	<brief_title>Study With Heptral Subjects With Liver Disease Due Alcohol Consumption</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Cholestasis , Intrahepatic</mesh_term>
	<mesh_term>Liver Diseases , Alcoholic</mesh_term>
	<criteria>Inclusion criterion : Signed informed consent give subject Age ≥ 18 year 75 year Chronic liver disease due alcoholic liver disease Compensated alcoholic liver disease , define Maddrey Score &lt; 32 treated pentoxifylline prednisolone within 6 month prior study History chronic alcohol use , define , history consumption &gt; 40 g alcohol per day female &gt; 80 g alcohol per day males 5 year prior enrolment Subjects abstain alcohol 2 week consume alcohol study Subjects Intrahepatic Cholestasis ( IHC ) : ALP : 1.5 x upper normal limit γGT : 3 x upper normal limit Subjects additional serum conjugate bilirubin ( SCB ) &gt; Upper Limit Normal ( ULN ) select initial IV treatment Subjects know hypersensitivity active substance ademetionine inactive ingredient Subjects extrahepatic cause cholestasis ( proven ultrasound describe medical history ) Diagnosis human immunodeficiency virus ( HIV ) medical history Subjects chronic liver disease ChildPugh class C Subjects decompensation stage ALD ( Maddrey Score &gt; 32 ) Subjects primary sclerosing cholangitis ( PSC ) Subjects primary biliary cirrhosis ( PBC ) Any form malignancy within past 5 year and/or basal cell carcinoma squamous cell carcinoma skin within past two year Subjects druginduced liver disease History active substance abuse ( oral , inhaled inject ) within one year prior study Subjects renal impairment ( creatinine level &gt; 2.0 mg/dL &gt; 150 µmol/l ) Subjects know genetic defect affect methionine cycle and/or cause homocystinuria and/or hyperhomocysteinemia ( e.g. , cystathionine betasynthase deficiency , Vitamin B12 metabolism defect ) know folate , Vitamin B6 B12 deficiency Subjects total parenteral nutrition year prior screen Subjects plan bariatric surgery ( jejunoileal bypass gastric weight loss surgery ) Subjects liver transplantation subject wait list liver transplantation Subjects follow disease medical history : Viral hepatitis ( serum positive HBcAb Hepatitis C Virus ( HCV ) RNA ) Evidence autoimmune liver disease Wilson´s disease Hemochromatosis Alpha1antitrypsin deficiency Subjects history biliary diversion History major depression bipolar disease Women childbearing potential : positive urine pregnancy test screen unwillingness use effective form birth control study . Breastfeeding woman Any condition , opinion investigator , justify patient 's inclusion study Investigational drug intake within one month prior study Active , serious medical disease ALD likely lifeexpectancy less five year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Intrahepatic Cholestasis</keyword>
</DOC>